Carlson, Eric G.
Lopez, Jennifer C.
Yamaguchi, Yukiko
Gibson, Jackson
Priceman, Saul J.
LaBarge, Mark A.
Article History
Received: 7 January 2025
Accepted: 1 May 2025
First Online: 15 May 2025
Declarations
:
: The present study was approved by the Human Subjects Committee and the Institutional Review Board (IRB) (17185) at City of Hope. Women were consented in person and sequentially; all women signed a City of Hope IRB-approved consent before trial entry. Breast organoids from reduction mammoplasties were prepared at the Lawrence Berkeley National Laboratory (Berkeley, CA) with approved IRB for sample distribution and collection from specific locations. Leukapheresis products (whole blood discard kits) were obtained from consented healthy donors under protocols approved by the City of Hope Internal Review Board.
: Not applicable.
: The authors declare no competing interests.